Results 81 to 90 of about 11,247 (186)

BONE FORMATION IN PAGET'S DISEASE

, 1967
1 . Normal and diseased bone was obtained by biopsy from five patients suffering from Paget's disease. The tissue was studied by histology, microradiography and quantitative fluorescence microscopy using tetracycline markers.
W. R. Lee
core   +1 more source

Bilateral Paget’s Disease of the Breast—Case Report of Long-Time Misdiagnosed Tumors with Underlying Ductal Carcinomas and Review of the Literature

Case Reports in Dermatological Medicine, 2014
Paget’s disease of the breast is often misdiagnosed. We report on a 72-year old patient with a history of 2.5 years without any malignant findings, followed by the identification of a bilateral Paget’s disease with bilateral breast cancers.
Dietrich Barth
doaj   +1 more source

Paget's disease of the breast

, 1996
Paget's disease of the breast is rare (1% of breast cancers), more often affects postmenopausal women and frequently shows a considerable diagnostic delay.
Tarquini A., Nicolosi A., Calo P. G., Malloci A.   +3 more
core  

Inflammatory cytokines in Paget's disease of bone

, 2014
This study was undertaken to evaluate the expression of inflammatory cytokines in patients with Paget's disease of bone (PDB). Serum levels of tumoral necrosis factor-α, interleukin 1β, interleukin-6 and interleukin-17 were measured in 51 patients with ...
Buss, Ziliani, Da Rosa, Julia Salvan, Fröde, Tânia Silvia, Werner de Castro, Gláucio Ricardo   +3 more
core   +1 more source

The “Boomerang” iliac crest flap for hemimandible reconstruction in rare Paget's Osteosarcoma: Case report and systematic literature review

Oral Oncology Reports
Paget's bone disease is a rare disease affecting the skeleton, inducing deformity and weakness of the affected bones and involving the splanchnocranium in only 8–23 % of all cases.
Olindo Massarelli, Samira Bucelli, Simone Benedetti   +2 more
doaj   +1 more source

Diphosphonates in Paget's disease.

, 1974
The diphosphonate, sodium etidronate (disodium ethane-1-hydroxy-1,1-diphosphonate) (E.H.D.P.), which inhibits the growth and dissolution of calcium phosphate crystals in vitro, was given at doses of 0, 1, 5, 10, or 20 mg. per kg.
Smith, R, Russell, RG, Woods, CG, Walton, RJ, Preston, C   +4 more
core   +1 more source

Mithramycin in Paget's disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974
Mithramycin, a cytotoxic agent, has been used to treat 6 patients with severe symptomatic Paget's disease of bone. Bone pain improved dramatically. Side-effects included hypocalcaemia and nausea, but were not serious. Mithramycin is valuable in selected cases of Paget's disease.S. Afr. Med. J., 48, 1328 (1974).
openaire   +3 more sources

STUDIES OF PAGET'S DISEASE (OSTEITIS DEFORMANS)

, 1951
Sarcoma complicating Paget's disease is uncommon; ninety-five cases have been collected and seven further cases are now reported. Sarcoma probably complicates less than 2 per cent of all cases of Paget's disease.
Max Lake
core   +1 more source

Paget's disease of bone in South Africa

, 1988
A survey of Paget's disease of bone in Johannesburg South Africa, has revealed a prevalence of 2.4% in whites aged 55 years and over, which is similar to some centres in Europe; it has also revealed an unexpectedly high prevalence of 1.3% among blacks ...
Guyer, P. B., Chamberlain, A. T.
core   +1 more source

An incidental finding of the Lincoln sign on FDG PET-CT in a patient with rectosigmoid adenocarcinoma giving rise to the diagnosis of Paget's disease

The Egyptian Journal of Radiology and Nuclear Medicine
Background Paget's disease is a metabolic disorder characterized by disorderly bone remodeling process of excessive osteoclastic and osteoblastic activities leading to a structurally disorganized appearance of the bone.
Muhammad Adib Abdul Onny, Sheila Shazlina Kemis Yahyah, Kavita Arumugam, Nor Salita Ali, Nashrulhaq Tagiling, Norazlina Mat Nawi   +5 more
doaj   +1 more source